Although the present study intersects with previous documentation in regard of miR-16 targeting TLR4/NF-κB signaling, it stands out for expanding the relatively well-recognized mechanism to IBS, indicating the promising potential of miR-16 in this new field. The gene discussed is NFKB1; the disease is irritable bowel syndrome.